沙布南·卡兹米

Shabnam Kazmi is a trusted leader in the pharmaceutical industry with over 30 years of experience and a track record of generating business value while improving the lives of patients with diseases of high unmet need such as oncology. Ms. Kazmi is currently the Chief Executive Officer of Asellus Ventures, a company investing in healthcare and providing global advisory services. Previously, Ms. Kazmi served as the Chief Business Officer at Shepherd Therapeutics in the field of rare cancer biotechnology innovation. She has also served in leadership roles at major pharmaceutical companies Bristol-Myers Squibb, Sanofi and Otsuka, leading new product launches, licensing and business development, global business management and P&L responsibilities for over $1B. Ms. Kazmi led joint ventures with American, European and Asian business partners, consistently delivering value by turning around businesses and building high performance teams. She has over 20 years of nonprofit board leadership and philanthropic service for which she has won multiple awards for her contributions. Ms. Kazmi is currently on the board of the Prevent Cancer Foundation, where she serves on the Finance and Audit Committee. Ms. Kazmi has double Bachelor’s degrees in Biochemistry and Economics from Smith College and an MBA from Harvard Business School.